Importance Bipolar disorder affects approximately 8 million adults in the US and
approximately 40 million individuals worldwide. Observations Bipolar disorder is …

Since their first application in psychiatry seventy years ago, antipsychotic drugs, besides
schizophrenia, have been widely used in the treatment of mood disorders. Such an …

Objective In this paper, we aimed at reviewing evidence‐based treatment options for bipolar
mania and proposed tentative evidence‐based clinical suggestions regarding the …

Clinical trials and real-world data have shown that long-acting injectable antipsychotics
(LAIs) might be an effective therapeutic option also for people with bipolar disorder (BD) …

Background Mood recurrences in bipolar disorder (BD) are often associated with poor
treatment adherence. Despite long-acting injectable antipsychotics (LAIs) may favor …

The topic of this narrative review is mood stabilizers. First, the author's definition of mood-
stabilizing drugs is provided. Second, mood-stabilizing drugs meeting this definition that …

Objective Schizophrenia is a chronic, debilitating psychiatric disorder with a high risk of
relapse. Nonadherence to medication is a significant contributor to poor outcomes. Although …

Treatment discontinuation is a major challenge in routine clinical settings. Despite poor
adherence to antipsychotic medication, long acting injectable (LAI) formulations are an …

Introduction Information on the off–label use of Long–Acting Injectable (LAI) antipsychotics
in the real world is lacking. In this study, we aimed to identify the sociodemographic and …

The aim of the study was to compare the real-world effectiveness of mood stabilizers and
antipsychotics in the prevention of psychiatric hospitalizations and treatment failure after …